{"id":"W2005373764","doi":"10.1007/s00223-012-9668-4","title":"A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data","year":2012,"lang":"en","type":"article","venue":"Calcified Tissue International","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Osteoporosis Canada","funders":"UCB Pharma; Procter and Gamble; Sanofi; Servier; Amgen; Pfizer; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Tolerability; Osteoporosis; Regimen; Bone mineral; Bisphosphonate; Randomized controlled trial; Dosing; Bone density; Internal medicine; Surgery; Urology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003813863,0.0001232514,0.0002730586,0.00009989161,0.00006023538,0.00001005993,0.0003124063,0.00008010066,0.0001499282],"category_scores_gemma":[0.0001680865,0.00008372925,0.00005936458,0.00009533727,0.0001190905,0.0001358314,0.00007833637,0.00008015965,0.00001213647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001258335,"about_ca_system_score_gemma":0.0001537708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004520468,"about_ca_topic_score_gemma":0.00001895698,"domain_scores_codex":[0.9985974,0.00002049656,0.0004146509,0.0002097369,0.0004540012,0.0003037131],"domain_scores_gemma":[0.9984446,0.0003512582,0.000181128,0.0005748361,0.0002866822,0.0001614861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01687897,0.01328421,0.04447828,0.001111472,0.00313463,0.00001766572,0.01149895,0.00008206609,0.5720488,0.01601246,0.02508229,0.2963702],"study_design_scores_gemma":[0.01850887,0.005706567,0.1412,0.0003656141,0.0006437568,0.0000919074,0.002033477,0.005018296,0.1896394,0.0001449055,0.6362817,0.0003654422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9297954,0.02067678,0.004165519,0.01848667,0.003167953,0.006233322,0.006371376,0.00008645569,0.01101645],"genre_scores_gemma":[0.9921687,0.0002727885,0.00462139,0.0001090094,0.0005075674,0.0001027754,0.0006295376,0.00002513421,0.001563068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6111994,"threshold_uncertainty_score":0.341438,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1056898434296992,"score_gpt":0.4060140360066105,"score_spread":0.3003241925769112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}